Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Nov;64(5):971–972. doi: 10.1038/bjc.1991.439

Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs.

C McMillan 1, J W Dundee 1, W P Abram 1
PMCID: PMC1977487  PMID: 1834156

Full text

PDF
971

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dundee J. W., Ghaly R. G., Bill K. M., Chestnutt W. N., Fitzpatrick K. T., Lynas A. G. Effect of stimulation of the P6 antiemetic point on postoperative nausea and vomiting. Br J Anaesth. 1989 Nov;63(5):612–618. doi: 10.1093/bja/63.5.612. [DOI] [PubMed] [Google Scholar]
  2. Dundee J. W., Ghaly R. G., Fitzpatrick K. T., Abram W. P., Lynch G. A. Acupuncture prophylaxis of cancer chemotherapy-induced sickness. J R Soc Med. 1989 May;82(5):268–271. doi: 10.1177/014107688908200508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dundee J. W., Yang J., McMillan C. Non-invasive stimulation of the P6 (Neiguan) antiemetic acupuncture point in cancer chemotherapy. J R Soc Med. 1991 Apr;84(4):210–212. doi: 10.1177/014107689108400409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dundee J. W., Yang J. Prolongation of the antiemetic action of P6 acupuncture by acupressure in patients having cancer chemotherapy. J R Soc Med. 1990 Jun;83(6):360–362. doi: 10.1177/014107689008300608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kris M. G., Gralla R. J., Tyson L. B., Clark R. A., Kelsen D. P., Reilly L. K., Groshen S., Bosl G. J., Kalman L. A. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. Cancer. 1985 Feb 1;55(3):527–534. doi: 10.1002/1097-0142(19850201)55:3<527::aid-cncr2820550310>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  6. Schmoll H. J. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes. Eur J Cancer Clin Oncol. 1989;25 (Suppl 1):S35–S39. [PubMed] [Google Scholar]
  7. Smith D. B., Newlands E. S., Spruyt O. W., Begent R. H., Rustin G. J., Mellor B., Bagshawe K. D. Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. Br J Cancer. 1990 Feb;61(2):323–324. doi: 10.1038/bjc.1990.62. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES